Showing results (41-50 of 105) with videos related to
Sort By:
Pageof 11
The Journal of Gene Medicine|June 2, 2004
Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cellsMarcus Nilsson, Johan Ljungberg, Johan Richter, et al.Clinical Neurology and Neurosurgery|October 8, 2020
Experiences of awake surgery in non-tumoural epilepsy in eloquent localizationsPatrick Vigren, Martin Eriksson, Hugues Duffau, et al.Journal of Neural Engineering|May 8, 2008
Diffuse reflectance spectroscopy measurements for tissue-type discrimination during deep brain stimulationJohan Antonsson, Ola Eriksson, Patric Blomstedt, et al.Plos One|January 31, 2017
Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid LeukemiaMohamed El Missiry, Henrik Hjorth-Hansen, Johan Richter, et al.European Journal of Haematology|February 3, 2016
Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalenceNiklas Gunnarsson, Fredrik Sandin, Martin Höglund, et al.Journal of Virology|January 15, 2005
Human immunodeficiency virus type 1 vectors with alphavirus envelope glycoproteins produced from stable packaging cellsBlair L Strang, Yasuhiro Takeuchi, Thomas Relander, et al.Bone|January 17, 2012
Murine ameloblasts are immunonegative for Tcirg1, the v-H-ATPase subunit essential for the osteoclast plasma proton pumpAntonius L J J Bronckers, Donacian M Lyaruu, Theodore J Bervoets, et al.Leukemia Research|October 7, 2016
Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuliStina Söderlund, Lisa Christiansson, Inger Persson, et al.Blood|March 13, 2013
Selective killing of candidate AML stem cells by antibody targeting of IL1RAPMaria Askmyr, Helena Ågerstam, Nils Hansen, et al.Proceedings of the National Academy of Sciences of the United States of America|September 7, 2006
Effective cell and gene therapy in a murine model of Gaucher diseaseIda Berglin Enquist, Eva Nilsson, Andreas Ooka, et al.Pageof 11